Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 2
2006 2
2007 1
2008 2
2009 2
2010 4
2011 1
2012 1
2013 4
2014 3
2015 3
2016 6
2017 7
2018 13
2019 17
2020 25
2021 16
2022 4
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 35477910

101 results
Results by year
Filters applied: . Clear all
Page 1
Impact of rituximab in Mexican patients with Multiple Sclerosis-A single-center retrospective study.
Bribiesca-Contreras E, García-Estrada C, Gómez-Figueroa E, Zertuche-Ortuño L, Rodríguez-Rivas R, Marcín-Sierra M, Delgado-Niño M, Rivas-Alonso V, Corona-Vázquez T, Flores-Rivera J. Bribiesca-Contreras E, et al. Mult Scler Relat Disord. 2022 Feb;58:103485. doi: 10.1016/j.msard.2021.103485. Epub 2022 Jan 4. Mult Scler Relat Disord. 2022. PMID: 35042092
Rituximab for relapsing-remitting multiple sclerosis.
He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H. He D, et al. Cochrane Database Syst Rev. 2013 Dec 6;(12):CD009130. doi: 10.1002/14651858.CD009130.pub3. Cochrane Database Syst Rev. 2013. PMID: 24310855 Review.
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.
Zecca C, Bovis F, Novi G, Capobianco M, Lanzillo R, Frau J, Repice AM, Hakiki B, Realmuto S, Bonavita S, Curti E, Brambilla L, Mataluni G, Cavalla P, Di Sapio A, Signoriello E, Barone S, Maniscalco GT, Maietta I, Maraffi I, Boffa G, Malucchi S, Nozzolillo A, Coghe G, Mechi C, Salemi G, Gallo A, Sacco R, Cellerino M, Malentacchi M, De Angelis M, Lorefice L, Magnani E, Prestipino E, Sperli F, Brescia Morra V, Fenu G, Barilaro A, Abbadessa G, Signori A, Granella F, Amato MP, Uccelli A, Gobbi C, Sormani MP. Zecca C, et al. Mult Scler. 2020 Oct;26(12):1519-1531. doi: 10.1177/1352458519872889. Epub 2019 Oct 1. Mult Scler. 2020. PMID: 31573386
101 results